GFACX
Price
$70.13
Change
+$0.36 (+0.52%)
Updated
Jun 30 closing price
Net Assets
319.43B
TBDQX
Price
$20.61
Change
+$0.11 (+0.54%)
Updated
Jun 30 closing price
Net Assets
393.12M
Interact to see
Advertisement

GFACX vs TBDQX

Header iconGFACX vs TBDQX Comparison
Open Charts GFACX vs TBDQXBanner chart's image
American Funds Growth Fund of Amer C
Price$70.13
Change+$0.36 (+0.52%)
VolumeN/A
Net Assets319.43B
PGIM Jennison Diversified Growth R6
Price$20.61
Change+$0.11 (+0.54%)
VolumeN/A
Net Assets393.12M
GFACX vs TBDQX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GFACX vs. TBDQX commentary
Jul 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and TBDQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 319B vs. TBDQX (393M). GFACX (0.00) and TBDQX (0.00) have matching dividends . GFACX was incepted earlier than TBDQX: GFACX (24 years) vs TBDQX (8 years). GFACX (1.36) is less costly to investors than TBDQX (1.09). TBDQX is a more actively managed with annual turnover of: 147.00 vs. GFACX (25.00). TBDQX has a lower initial minimum investment than GFACX: TBDQX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 9.02 vs. TBDQX (0.74). GFACX return over 5 years is better than : 38.43 vs. TBDQX (28.77).
GFACXTBDQXGFACX / TBDQX
Total Expense Ratio1.360.44309%
Annual Report Gross Expense Ratio1.361.09125%
Fund Existence24 years8 years-
Gain YTD9.4267.162132%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets319B393M81,170%
Annual Yield % from dividends0.000.00-
Returns for 1 year9.020.741,223%
Returns for 3 years50.8976.5766%
Returns for 5 years38.4328.77134%
Returns for 10 years64.67N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LSTA2.900.10
+3.54%
Lisata Therapeutics
HUBS556.636.00
+1.09%
HUBSPOT
CDTX48.71-0.74
-1.50%
Cidara Therapeutics
RUSHB52.48-1.18
-2.20%
Rush Enterprises
FSP1.64-0.06
-3.53%
Franklin Street Properties Corp